Nanoform Q2 2025 report: Continued progress on many fronts, supportive first preliminary pivotal nanoenzalutamide study results
Nanoform Finland Plc | Company Release | August 21, 2025…
Invitation to Nanoform’s Q2 2025 Report Presentation
Nanoform Finland Plc | Press Release | August 07, 2025…
Nanoform Finland Plc – Manager’s Transactions – Jeanne Thoma
Nanoform Finland Plc | Company Release | June 17, 2025…
Nanoform Finland Plc – Manager’s Transactions – Miguel Calado
Nanoform Finland Plc | Company Release | June 17, 2025…
Nanoform Finland Plc – Manager’s Transactions – Albert Hæggström
Nanoform Finland Plc | Company Release | June 17, 2025…
Share subscriptions based on the resolution by Nanoform Finland Plc’s Annual General Meeting 2025 on remuneration of the Board of Directors
Nanoform Finland Plc | Company Release | June 17, 2025…
Nanoform Q1 2025 report: Deal mosaic emerge and commercial value clearly seen in our CESS® technology
Nanoform Finland Plc | Company Release | May 20, 2025…
Invitation to Nanoform’s Q1 2025 Report Presentation
Nanoform Finland Plc | Press Release | May 06, 2025…